Thesis (Ph. D.)--Ohio State University, 2008. / Title from first page of PDF file. Includes bibliographical references (p. 160-164).

Thesis (Ph. D.)--Ohio State University, 2008. / Title from first page of PDF file. Includes bibliographical references (p. 193-199).

Thesis (Ph. D.)--Oregon State University, 2005. / Printout. Includes bibliographical references. Also available via the World Wide Web.

Thesis (M.S.)--Oregon State University, 2008. / Printout. Includes bibliographical references. Also available on the World Wide Web.

As antibiotic resistant bacterial strains are becoming more prevalent in healthcare settings, it is necessary to find alternative methods of detecting and treating these infections. One of the antibiotic resistant strains of interest is the carbapenem-resistant Enterobacteriaceae (CRE). CREs have the ability to evade some of the most potent antibiotics currently in use and employ carbapenemases to negate the effect of antibiotics. The three most common carbapenemase genes, found in carbapenem-resistant Enterobacteriaceae along with a gene found only in Escherichia coli were chosen to create a qPCR assay for rapid detection of resistant infections. The carbapenemase genes are KPC, VIM and NDM and the E. coli gene is uidA, a β-glucuronidase gene. Consensus sequences were obtained from each of the genes to account for the many variants of each gene. We were able to triplex the assay and test it against a library for twenty isolates varying by which gene they contain. Additional research has been conducted on the library of carbapenem-resistant Enterobacteriaceae using bacteriophages or phage. The Phage Hunters class isolated and identified twenty phage that infect K. pneumoniae. Out of the twenty phage, seven phage were able to effectively infect carbapenem-resistant K. pneumoniae.

Thesis (MSc. (Medical Sciences)) -- University of Limpopo, 2015 / Introduction: Multidrug-resistant tuberculosis (MDR-TB) caused by resistance to at least rifampicin (RIF) and isoniazid (INH) drugs is a growing public health concern in South Africa. The detection of MDR-TB still relies on culture despite advancement in molecular diagnostic technology. Currently MTBDRplus and GeneXpert are the only available assays used in rapid diagnosis of MDR-TB using chromosomal mutations in drug target regions. Some strains are missed by these assays due to their limitation in mutational detection profile. Novel Seegene Anyplex assays simultaneously detect TB and resistance to RIF and INH using fifteen and six mutational probes, respectively within 3 hours. Limpopo Province has limited information on the circulating strains of TB. Aim: To determine drug-resistant Mycobacterium tuberculosis (M. tuberculosis) mutations using Anyplex™ MTB/NTM/MDR-TB real time assay and characterise the drug-resistant strains. Methods: We prospectively collected 204 clinical samples at Modimolle MDR-TB unit and retrospectively used 104 culture isolates from MRC laboratory in Pretoria. The MTBDRplus assay was used to screen for M. tuberculosis and drug resistant mutations to RIF and INH drugs. Anyplex™ MTB/NTM/MDR-TB assay was used for rapid detection of M. tuberculosis and drug resistance to RIF and INH within 3 hours. The discordance between phenotypic and genotypic assays was resolved by sequencing and the Anyplex™ resistant profiles were spoligotyped. Diagnostic data was collected from NHLS and MRC databases and analysed using the Microsoft excel and Epi Info version 3.5. Descriptive statistics (percentages and frequencies) were used to explain proportions. Results: The Anyplex™ MTB/NTM assay detected M. tuberculosis in 69/111(62%) and 100/104 (96%) of clinical and culture samples respectively. The sensitivities, specificity, PPV and NPV obtained for both RIF and INH resistance by Anyplex™ MDR-TB assay were 67%, 59%, 67%, 55% and 15%, 100%, 100% and 17%, respectively. Anyplex™ MTB/NTM/MDR-TB resolved 23/45 (51%) of discordant vi samples. Sequencing of remaining discordant isolates revealed L511P, L533P and D516Y mutations within rpoB gene. A novel R385W mutation within katG was also detected. Spoligotyping of Anyplex™ MDR-TB resistant clinical isolates revealed Euro American clade with 20% followed by 15% Manu2, 5% East African Indian, 5% H37Rv, 5% atypical and 50% were orphans. Conclusion: The novel Anyplex™ MTB/NTM/MDR-TB assay is a rapid and valid technique for detecting M. tuberculosis and most common mutations conferring resistance to RIF and INH. However further investigations are required, as the assay has a lower sensitivity as compared to already endorsed techniques. / National Research Foundation (NRF) and University of Limpopo TB Grant

No description available.

Background: Resistant hypertension (RH) is defined as blood pressure (BP) that remains elevated (>140/90mmHg) despite being treated with an antihypertensive regimen of 3 or more medications from different classes, including a long-acting calcium channel blocker, an angiotensin converting enzyme inhibitor or angiotension receptor blocker and a diuretic. The prevalence of RH in South Africa is currently unknown, however, clinical reports suggest that it is not rare. Patients with RH are significantly predisposed to cardiovascular (CV) diseases compared to patients with controlled BP. Consequences of RH include left ventricular hypertrophy, heart failure, ischaemic heart disease, chronic kidney disease leading to end-stage renal disease, stroke, vascular dementia, CV death and peripheral arterial disease. A proportion of patients with RH who never achieve BP control despite maximal medical treatment, represent a potentially novel and distinctive phenotype which is different from RH patients whose BP canbe controlled. Recognising and categorising such patients becomes the initial and crucial step in stratifying phenotypes and defining mechanisms of treatment resistance. Objectives: The aim of this study was to identify patients with resistant uncontrolled hypertension (RUH) and compare phenotypes in these patients to resistant controlled hypertensives (RCH). Methods: We enrolled 50 patients from the Groote Schuur Hospital Hypertension Clinic: a teriary referral hospital for RH. Patients on 4 or more antihypertensive medication including a diuretic, with BP< 140/90mmHg were considered RCH, and those with BP ≥ 140/90 considered RUH. Assessments included clinical examination, electrocardiography, echocardiography, applanation tonometry, serum biomarkers and cardiovascular magnetic resonance (CMR - which included biventricular volumes and function, myocardial strain, tissue characteristics and late gadolinium enhancement - LGE). Results: Thirty were diagnosed with RUH and twenty with RCH. Patients with RUH were more likely to have a longer duration since diagnosis of hypertension (10.5±10.7 vs. 3.6±3.4, p=0.02) and more likely to be on treatment that included an ACE-inhibitor (90% vs. 58%, p=0.01). As expected, patients with RUH had significantly higher systolic BP (155.6±21.6 vs. 137.8±16.5 mmHg, p< 0.001), diastolic BP (88.4±14.5 vs. 77.5±13.6 mmHg, p= 0.03), mean arterial BP (115.4±17.2 vs 101±15.3 mmHg, p= 0.004) and pulse pressure (67.3±14.2 vs. 60.1±12.4 mmHg, p=0.001). Further, RUH patients had significantly lower large artery elasticity (12.5±4 vs 14.7±3.8ml/mmHgx100, p=0.08) and lower small artery elasticity (4.1±2.1 vs. 6.9±3.6ml/mmHgx100, p< 0.001). RUH patients also had a higher systemic vascular resistance (1754±418.4 vs. 1363±371.5dyneXsecXcm-5, p=0.002). On CMR, RUH patients had lower right ventricular (RV) end-systolic and end-diastolic volumes (p=0.02), as well as higher indexed left ventricular mass (LVMI) (61.6±17.6 vs 52.9±13.9 g/m2 , p= 0.06). There were no differences in native T1, extracellular volume quantification and LGE volume fraction between RUH and RCH patients. Conclusions: Patients with RUH have a greater involvement and more severe CV phenotype, that is likely to result in increased CV morbidity and mortality, including greater target end organ damage as a result of vascular adaptations and concentric remodeling.

<p dir="ltr">During atmospheric re-entry, the hypersonic leading edges can experience enormous heat fluxes, with surface temperatures greater than 1600℃ expected. While carbon/carbon (C/C) is a candidate material for leading edge structures, it is prone to oxidation and ablation damage above 500℃. Ablation-resistant coatings can protect the C/C, while emissivity can be engineered to lower the leading-edge surface temperature via radiative cooling. In this dissertation, a novel bilayer coating system and a multilayer coating system based on individual layers consisting of ultra-high temperature ceramics (borides, carbides), refractory oxides (zirconia), and rare-earth oxide as emissivity modifiers were applied to a C/C surface via pack cementation and plasma spray. Ablation tests were performed to evaluate the efficacy of the multilayer coatings in simulated high heat flux environments. <a href="" target="_blank">The spectral emittance of the rare-earth modified topcoat ZrO₂ was measured at high temperatures up to 1200</a>℃ using a benchtop emissometer. ZrO₂ stabilized with 6 mol% Sm₂O₃ demonstrated a maximum spectral emissivity of 0.99 at λ = 12.5 µm proving its effectiveness in cooling the leading edge surface through enhanced thermal radiation.</p><p dir="ltr"><a href="" target="_blank">The bilayer coating system comprised of Sm₂O₃-stabilized ZrO₂ topcoat layer and SiC intermediate sublayer on C/C. </a><a href="" target="_blank">This coating significantly improved the ablation resistance of C/C by reducing the mass ablation rate by ~71%. Despite a significant thermal expansion coefficient mismatch between the substrate and the coating, a well-defined mechanical adhesion characterized by the anchors was observed in pre- and post-ablated coating microstructures, indicating their influence on improving ablation resistance.</a></p><p dir="ltr"><a href="" target="_blank">The multilayer coating architecture consisted of SiC, ZrB₂-SiC, ZrC-ZrO₂ sublayers and a Sm₂O₃-ZrO₂ topcoat. The as-sprayed coating microstructure demonstrated well-defined adhesion between the layers and the substrate without forming major voids or cracks. The multilayer coating with optimized</a> sublayer thickness demonstrated excellent ablation and mass erosion resistance as they reduced the mass ablation rate of C/C by ~90% after being subjected to an aggressive oxyacetylene torch heating for 60 s. During testing, the Sm₂O₃-stabilized ZrO₂ topcoat acted as oxygen and thermal barrier, protecting the underlying sublayers from oxidation-induced damage while maintaining a constant surface temperature of ~2100 ℃. Additionally, the high spectral emittance of topcoat material contributed to efficient outward heat transfer via thermal radiation from the external surface while maintaining a constant temperature.</p>

Compared to conventional materials, polymer matrix composites (PMCs) have a number of attractive properties, including light weight, easiness of installation, potential to lower system-level cost, high overall durability, and less susceptibility to environmental deterioration. However, PMCs are vulnerable to fire such that they degrade, decompose, and sometimes yield toxic gases at high temperature. The degradation and decomposition of composites lead to loss in mass, resulting in loss in mechanical strength. This research aims to improve the structural integrity of the PMCs under fire conditions by designing and optimizing a fire retardant nanopaper coating, and to fundamentally understand the thermal response and post-fire mechanical behavior the PMCs through numerical modeling. Specifically, a novel paper-making process that combined carbon nanofiber, nanoclay, exfoliated graphite nanoplatelet, and ammonium polyphosphate into a self-standing nanopaper was developed. The nanopaper was then coated onto the surface of the PMCs to improve the fire retardant performance of the material. The morphology, thermal stability, flammability, and post-fire flexural modulus of the nanopaper coated-PMCs were characterized. The fire retardant mechanism of the nanopaper coating was studied. Upon successfully improving the structure integrity of the PMCs by the nanopaper coatings, a thermal degradation model that captured the decomposition reaction of the iv polymer matrix with a second kind boundary condition (constant heat flux) was solved using Finite Element (FE) method. The weak form of the model was constructed by the weighted residual method. The model quantified the thermal and post-fire flexural responses of the composites subject to continuously applied heat fluxes. A temperature dependent post-fire residual modulus was assigned to each element in the FE domain. The bulk residual modulus was computed by assembling the modulus of each element. Based on the FE model, a refined Finite Difference (FD) model was developed to predict the fire response of the PMCs coated with the nanopapers. The FD model adopted the same post-fire mechanical evaluation method. However, unlike the FE model, the flow of the decomposed gas, and permeability and porosity of the composites were taken into account in the refined FD model. The numerical analysis indicated that the thickness and porosity of the composites had a profound impact on the thermal response of the composites. The research funding from the Office of Naval Research (ONR) and Federal Aviation Administration Center of Excellence for Commercial Space Transportation (FAA COE AST) is acknowledged.